Amirzadegan, Jasmine
Vouffo, Edwige Chiogo
Lan, Ling
Navarro Almario, Eileen
Avigan, Mark I.
Hayashi, Paul H. https://orcid.org/0000-0002-5371-1020
Funding for this research was provided by:
Oak Ridge Institute for Science and Education
Article History
Received: 12 May 2025
Accepted: 8 August 2025
First Online: 31 August 2025
Declarations
:
: The Research Participation Program at the US Food and Drug Administration administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the US Food and Drug Administration.
: The authors have no conflicts of interest to declare.
: The conclusions and views in this manuscript are the authors and do not represent an official position of the Food and Drug Administration, the Department of Health and Human Services, or the US Government.
: Not applicable. Only de-identified data are used.
: Not applicable. Only de-identified data used.
: Data sharing is not permitted by the FDA. Data are proprietary to drug developers.
: Not applicable.
: Not applicable.
: JA: study design, data analysis, manuscript writing; ECV: data acquisition, data analysis; LL: data acquisition; EN: study design, data analysis, manuscript writing; MIA: study design, manuscript writing; PHH: data acquisition; study design, data analysis, manuscript. All authors read and approved the final version of the manuscript.